Search

Your search keyword '"Lu, Min-Chi"' showing total 441 results

Search Constraints

Start Over You searched for: Author "Lu, Min-Chi" Remove constraint Author: "Lu, Min-Chi"
441 results on '"Lu, Min-Chi"'

Search Results

101. In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

103. Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976]

105. In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

106. Detection of EBV infection and gene expression in oral cancer from patients in Taiwan by microarray analysis

110. Corrigendum to “Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009” [Diagn Microbiol Infect Dis 2015;81(4):290–295]

111. Hypervirulence and carbapenem resistance: two distinct evolutionary directions that led high-risk Klebsiella pneumoniae clones to epidemic success.

112. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: Results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009

113. Emergence, transmission and phylogeny of meticillin-resistant Staphylococcus aureus sequence type 8 (USA300) in Taiwan.

114. In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART).

115. Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureusamong nasal carriage strains isolated from emergency department patients and healthcare workers in central Taiwan

116. Predominance of methicillin-resistant Staphylococcus aureusin the residents and environments of long-term care facilities in Taiwan

118. Corrigendum to “Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)” [J Microbiol Immunol Infect 49 (2016) 969–976]

125. The experience of preventing needlestick injury by insulin pen

126. The effectiveness of reducing the amount of antibiotic resistant strains by promoting the antibiotic stewardship via antibiotic management team of a medical center

127. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009

129. Clinical and molecular features of MDR livestock-associated MRSA ST9 with staphylococcal cassette chromosome mecXII in humans.

131. Genotoxic Klebsiella pneumoniae in Taiwan

136. First identification of methicillin-resistant Staphylococcus aureus MLST types ST5 and ST45 and SCCmec types IV and Vt by multiplex PCR during an outbreak in a respiratory care ward in central Taiwan

137. Assessment of hypermucoviscosity as a virulence factor for experimental Klebsiella pneumoniaeinfections: comparative virulence analysis with hypermucoviscosity-negative strain

138. Genomic diversity of citrate fermentation in Klebsiella pneumoniae

143. Rates of susceptibility of carbapenems, ceftobiprole, and colistin against clinically important bacteria collected from intensive care units in 2007: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)

144. Differences in IL-8 in serum and exhaled breath condensate from patients with exacerbated COPD or asthma attacks.

145. Molecular Epidemiology and Antimicrobial Resistance of Methicillin-Resistant Staphylococcus aureus Bloodstream Isolates in Taiwan, 2010.

146. Genotoxic Klebsiella pneumoniae in Taiwan.

147. Ribotypes and antimicrobial susceptibility profiles of clinical Clostridioides difficileisolates: a multicenter, laboratory-based surveillance in Taiwan, 2019-2021

148. Relationship between the distribution of cefepime minimum inhibitory concentrations and detection of extended-spectrum β-lactamase production among clinically important Enterobacteriaceae isolates obtained from patients in intensive care units in Taiwan: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2007

150. Risk Factors and Prognoses of Invasive CandidaInfection in Surgical Critical ill Patients with Perforated Peptic Ulcer

Catalog

Books, media, physical & digital resources